ClinicalTrials.govpublic full text
Selumetinib in Combination With Gefitinib in NSCLC Patients
non-small cell lung cancer (nsclc), nsclc, egfr mutation, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828813
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.